Melanie Sena

Covance adds workspace and scientists to biologics team in Indianapolis facility.

RCA opens a new office in Warsaw, Poland.

AmerisourceBergen to establish a joint venture for specialty distribution with Profarma.

Crystal Pharmatech selects Freeslate for its CM Protege PharmD System.

Catalent increases its minority investment in Redwood Bioscience for engineering ADCs.

FDA approves Xolair (omalizumab) for the treatment of a rare skin disease known as chronic idiopathic urticarial.

Almac expands technical, project, and operational resources in Asia.

$2.6 billion transaction combines Patheon and DSM Pharmaceutical to create CDMO, DPx.

Impact Analytical's facility in Michigan adds staff and instrumentation.

Beckman Coulter partners with Wyatt Technology to develop and market products for nanoparticle characterization.

Johnson Controls launches Integrated Laboratory Services for R&D facility operations and scientific productivity.

Waters celebrates ten-year anniversary of the ACQUITY UPLC System.

ACQUITY QDa Detector Increases Productivity

AbbVie launches art initiative designed to explore impact of chronic inflammatory diseases.

The cyclotron is key component of MPI Research's Translational Imaging Center in Mattawan, Michigan.

FDA approves the orphan drug Myalept for the treatment of leptin deficiency.

Fluid Imaging Technologies calls for submissions for its Life Sciences & Materials Research Grant.

Nuevolution enters a license agreement with a subsidiary of Merck for small molecule compounds.

Metrics opens a new laboratory to support fast-track development of pharmaceutical products in North Carolina.

EMD Serono assigns operational changes.

DIR Technologies will work with Pfizer to perform a three-month trial of the company's packaging integrity testing systems.

Ben Venue issues a voluntary patient level recall of Acetylcysteine Solution 10% due to glass particle in vial.

Ecolab's Shield Medicare division will now be called Ecolab Contamination Control.

Mallinckrodt acquires Cadence Pharmaceuticals for $1.3 million.

Novartis is named among the 2014 Corporate Knights Global 100.

AstraZeneca completes the acquisition of the entirety of BSM's interests in the companies' diabetes alliance.

Vanda Pharmaceuticals receives approval from FDA for Hetlioz for the treatment of Non-24.

AbbVie will open its first manufacturing facility in Singapore.

ProcessPro releases Premier 10.4 software.

Partners MPI Research, inviCRO, and 3D Imaging announce name of new facility for molecular imaging, autoradiography, and animal modeling.